Newsletter | April 9, 2021

04.09.21 -- Five Common Clinical Supply Chain Speedbumps

Who’s Watching Your Supply Chain? Strategies For Mitigating Risk In Clinical Trials

With increasing costs of clinical trials and the advantages of being first-to-market, it’s time to take a closer look at your supply chain to ensure it delivers with speed, efficiency, quality, and within your budget. This article is a guide through numerous considerations to decide whether to build your capability, outsource it, or create a hybrid insource/outsource model.

Factoring The “What Ifs” Into Supply Forecasting

Growing urgency in the biopharmaceutical industry to speed new products to market leads to greater appreciation for supply forecasting as a strategic and highly complex success factor. Review considerations for developing a supply plan, the influence of early decisions and their impact on outcomes as a trial progresses, and how decisions can put patients and the trial at risk.

5 Common Clinical Supply Chain Speedbumps

Clinical trials are so complex, you can’t leave anything to chance. Instead, you need to connect planning and oversight from sourcing to shipping and master such requirements as cold chain, border slowdowns, and data privacy. Learn about five common issues and how to solve them.

Considerations For Your First Clinical Trial

For a small and emerging biopharma, moving into the clinical trial phase of development can be overwhelming, and clinical research organizations (CROs) do not typically manage the comprehensive clinical trial supply chain. Discover seven best practices to help ensure a successful trial.